Welcome to SpeeDx

SpeeDx Pty Ltd is focused on the development of catalytic nucleic acid enzymes for medical diagnostics and other applications. Our key technologies include MNAzymes and DNAzymes which provide the basis for a suite of highly specific and cost-effective methods for analysis of biological materials.

MNAzymes are a powerful tool for analyte detection, for use in either an isothermal direct detection format, or when linked to quantitative PCR (qPCR).

MNAzyme qPCR possesses superior multiplex capacity, thus allowing users to both increase their throughput and include internal controls, while at the same time, reducing assay development time and cost. This technology is available for immediate licensing.